FDA warns Facebook marketeers; DNAnexus adds PacBio assembly capabilities;

> The FDA hit four companies with warning letters for making promotional claims on Facebook ($FB). Piece

> DNAnexus began offering whole genome assembly of PacBio long read data and struck a deal with Intermountain Cancer Genomics. Release | More

> WuXi ($WX) talked up its expansion into e-commerce through a website and mobile app. Transcript

> DIA previewed a new version of its trial master file reference model that features an XML-based mechanism. More (PDF)

> MedGenome began hunting for up to $15 million to expand its genomic testing offering. Article

> IBM ($IBM) bought AlchemyAPI to boost the deep-learning capabilities of Watson. Release

> OmniComm Systems ($OMCM) struck a multiyear deal to provide its software for Phase I trials to Icon ($ICLR). News

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.